Regeneron Pharmaceuticals, Inc.
Multispecific Antigen-Binding Molecules for Cell Targeting and Uses Thereof

Last updated:

Abstract:

The present invention provides multispecific antigen-binding molecules that bind both a T-cell antigen (e.g., CD3) and a target antigen (e.g., a tumor associated antigen, a viral or bacterial antigen), and which include a single polypeptide chain that is multivalent (e.g., bivalent) with respect to T-cell antigen binding, and uses thereof.

Status:
Application
Type:

Utility

Filling date:

14 Aug 2020

Issue date:

18 Feb 2021